Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin ER for painful diabetic peripheral neuropathy
CTR20241391Phase 3Completed
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neuralgia comparing Pregabalin extended-release with Placebo (2 arms). Primary endpoint: Change from baseline in weekly mean NRS pain score at Week 13. Started Apr 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on CTR20241391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241391.